SAN FRANCISCO – July 14, 2015 – Castlight Health, Inc. (NYSE: CSLT), a leader in enterprise healthcare management (EHM), today announced that it has scheduled a conference call to review its second quarter 2015 results (ended June 30, 2015) for Wednesday, August 5, 2015 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).
To listen to the conference call live, dial (877) 201-0168. The conference ID number is 80918941. Please dial in at least five minutes before the scheduled start time. A live webcast can be accessed at www.castlighthealth.com.
A replay of the call will be available, beginning at approximately 5:00 p.m. Pacific Time on August 5, 2015 for one week, at (855) 859-2056, and archived via webcast at www.castlighthealth.com. The replay access code is 80918941.
A press release highlighting the company’s results will be issued in advance of the conference call and will be accessible at www.castlighthealth.com in the Investor Relations section.
About Castlight Health
Castlight Health, Inc. (NYSE:CSLT) is a leader in Enterprise Healthcare Management. We believe great healthcare builds great business, and U.S. enterprises can gain control over the $620 billion spent annually on healthcare, transforming a crippling cost into a strategic business advantage. Recognized as a top 2014 software platform by the HR Technology Conference & Exposition, the Castlight Enterprise Healthcare Cloud enables employers to understand and manage their healthcare investments while helping employees make the best possible healthcare decisions. Castlight is a great place to work, honored with a Glassdoor Employees’ Choice award and recognized by Rock Health for Diversity in Leadership. For more information visit www.castlighthealth.com. Follow us on Twitter and LinkedIn and Like us on Facebook. Source: Castlight Health.
Copyright 2015 Castlight Health, Inc. Castlight Health® is the registered trademark of Castlight Health, Inc. Other company and product names may be trademarks of the respective companies with which they are associated.